{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:05:56Z","timestamp":1782601556027,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T00:00:00Z","timestamp":1290470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s11894-010-0166-4","type":"journal-article","created":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T00:01:15Z","timestamp":1290384075000},"page":"40-48","source":"Crossref","is-referenced-by-count":50,"title":["Bone Disorders in Chronic Liver Diseases"],"prefix":"10.1007","volume":"13","author":[{"given":"Bruce A.","family":"Luxon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,23]]},"reference":[{"issue":"2","key":"166_CR1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/TP.0b013e3181c6910f","volume":"89","author":"M Courbebaisse","year":"2010","unstructured":"Courbebaisse M, Souberbielle JC, Thervet E: Potential nonclassical effects of vitamin D in transplant recipients. Transplantation 2010, 89(2):131\u2013137.","journal-title":"Transplantation"},{"issue":"12","key":"166_CR2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ncpgasthep0637","volume":"3","author":"BA Crawford","year":"2006","unstructured":"Crawford BA, Labio ED, Strasser SI, et al.: Vitamin D replacement for cirrhosis-related bone disease. Nat Clin Pract Gastroenterol Hepatol 2006, 3(12):689\u2013699.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"166_CR3","first-page":"1","volume":"843","author":"WHO","year":"1994","unstructured":"WHO: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994, 843:1\u2013129.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"166_CR4","doi-asserted-by":"crossref","unstructured":"Collier JD, Ninkovic M, Compston JE: Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 2002, 50 Suppl 1(1):i1\u20139.","DOI":"10.1136\/gut.50.suppl_1.i1"},{"issue":"3","key":"166_CR5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0016-5085(03)01062-X","volume":"125","author":"WD Leslie","year":"2003","unstructured":"Leslie WD, Bernstein CN, Leboff MS: AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003, 125(3):941\u2013966.","journal-title":"Gastroenterology"},{"issue":"7041","key":"166_CR6","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","volume":"312","author":"D Marshall","year":"1996","unstructured":"Marshall D, Johnell O, Wedel H: Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996, 312(7041):1254\u20131259.","journal-title":"BMJ"},{"issue":"1","key":"166_CR7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/hep.1840070127","volume":"7","author":"AJ Stellon","year":"1987","unstructured":"Stellon AJ, Webb A, Compston J, et al.: Low bone turnover state in primary biliary cirrhosis. Hepatology 1987, 7(1):137\u2013142.","journal-title":"Hepatology"},{"key":"166_CR8","doi-asserted-by":"crossref","unstructured":"Guanabens N, Pares A: Liver and bone. Arch Biochem Biophys 2010, ePub ahead of print.","DOI":"10.1016\/j.abb.2010.05.030"},{"issue":"6","key":"166_CR9","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","volume":"95","author":"CH Janes","year":"1995","unstructured":"Janes CH, Dickson ER, Okazaki R, et al.: Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 1995, 95(6):2581\u20132586.","journal-title":"J Clin Invest"},{"issue":"1","key":"166_CR10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0016-5085(89)90783-X","volume":"96","author":"TH Diamond","year":"1989","unstructured":"Diamond TH, Stiel D, Lunzer M, et al.: Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989, 96(1):213\u2013221.","journal-title":"Gastroenterology"},{"issue":"2","key":"166_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF03179904","volume":"56","author":"A Cemborain","year":"2000","unstructured":"Cemborain A, Castilla-Cortazar I, Garcia M, et al.: Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis. J Physiol Biochem 2000, 56(2):91\u201399.","journal-title":"J Physiol Biochem"},{"issue":"11","key":"166_CR12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrgastro.2009.166","volume":"6","author":"IA Nakchbandi","year":"2009","unstructured":"Nakchbandi IA, van der Merwe SW: Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol 2009, 6(11):660\u2013670.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"166_CR13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00223-001-2028-4","volume":"69","author":"M Ninkovic","year":"2001","unstructured":"Ninkovic M, Love SA, Tom B, et al.: High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int 2001, 69(6):321\u2013326.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"166_CR14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/hep.21852","volume":"46","author":"J Collier","year":"2007","unstructured":"Collier J: Bone disorders in chronic liver disease. Hepatology 2007, 46(4):1271\u20131278.","journal-title":"Hepatology"},{"issue":"5","key":"166_CR15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0168-8278(98)80253-5","volume":"29","author":"P Angulo","year":"1998","unstructured":"Angulo P, Therneau TM, Jorgensen A, et al.: Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J Hepatol 1998, 29(5):729\u2013735.","journal-title":"J Hepatol"},{"issue":"4","key":"166_CR16","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/hep.21805","volume":"46","author":"MM Guichelaar","year":"2007","unstructured":"Guichelaar MM, Schmoll J, Malinchoc M, et al.: Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors. Hepatology 2007, 46(4):1198\u20131207.","journal-title":"Hepatology"},{"issue":"4","key":"166_CR17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2004.11.035","volume":"42","author":"N Guanabens","year":"2005","unstructured":"Guanabens N, Pares A, Ros I, et al.: Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 2005, 42(4):573\u2013577.","journal-title":"J Hepatol"},{"issue":"6","key":"166_CR18","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2006.09.012","volume":"131","author":"M Solaymani-Dodaran","year":"2006","unstructured":"Solaymani-Dodaran M, Card TR, Aithal GP, et al.: Fracture risk in people with primary biliary cirrhosis: a population-based cohort study. Gastroenterology 2006, 131(6):1752\u20131757.","journal-title":"Gastroenterology"},{"issue":"2","key":"166_CR19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s005350050076","volume":"33","author":"K Masaki","year":"1998","unstructured":"Masaki K, Shiomi S, Kuroki T, et al.: Longitudinal changes of bone mineral content with age in patients with cirrhosis of the liver. J Gastroenterol 1998, 33(2):236\u2013240.","journal-title":"J Gastroenterol"},{"issue":"12","key":"166_CR20","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3748\/wjg.v11.i12.1843","volume":"11","author":"I Schiefke","year":"2005","unstructured":"Schiefke I, Fach A, Wiedmann M, et al.: Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 2005, 11(12):1843\u20131847.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"166_CR21","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00198-005-1934-0","volume":"16","author":"P Guggenbuhl","year":"2005","unstructured":"Guggenbuhl P, Deugnier Y, Boisdet JF, et al.: Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 2005, 16(12):1809\u20131814.","journal-title":"Osteoporos Int"},{"issue":"2","key":"166_CR22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00298430","volume":"57","author":"P Peris","year":"1995","unstructured":"Peris P, Guanabens N, Pares A, et al.: Vertebral fractures and osteopenia in chronic alcoholic patients. Calcif Tissue Int 1995, 57(2):111\u2013114.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"166_CR23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/rheumatology\/33.1.52","volume":"33","author":"M Navasa","year":"1994","unstructured":"Navasa M, Monegal A, Guanabens N, et al.: Bone fractures in liver transplant patients. Br J Rheumatol 1994, 33(1):52\u201355.","journal-title":"Br J Rheumatol"},{"issue":"5","key":"166_CR24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/lt.20104","volume":"10","author":"RP Sokhi","year":"2004","unstructured":"Sokhi RP, Anantharaju A, Kondaveeti R, et al.: Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl 2004, 10(5):648\u2013653.","journal-title":"Liver Transpl"},{"issue":"2","key":"166_CR25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.1840140215","volume":"14","author":"R Eastell","year":"1991","unstructured":"Eastell R, Dickson ER, Hodgson SF, et al.: Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991, 14(2):296\u2013300.","journal-title":"Hepatology"},{"issue":"5","key":"166_CR26","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.transproceed.2006.02.074","volume":"38","author":"F Atamaz","year":"2006","unstructured":"Atamaz F, Hepguler S, Karasu Z, et al.: The prevention of bone fractures after liver transplantation: experience with alendronate treatment. Transplant Proc 2006, 38(5):1448\u20131452.","journal-title":"Transplant Proc"},{"issue":"3","key":"166_CR27","first-page":"445","volume":"45","author":"A Pares","year":"2006","unstructured":"Pares A, Guanabens N, Pares A, et al.: Treatment of bone disorders in liver disease. Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment. J Hepatol 2006, 45(3):445\u2013453.","journal-title":"Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment. J Hepatol"},{"issue":"2","key":"166_CR28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cld.2008.02.005","volume":"12","author":"A Pares","year":"2008","unstructured":"\u2022 Pares A, Guanabens N: Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment. Clin Liver Dis 2008, 12(2):407\u2013424. A good review of osteoporosis in primary biliary cirrhosis with discussions about the prevalence, pathogenesis, and recommendations for treatment.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"166_CR29","first-page":"47","volume":"89","author":"JS Crippin","year":"1994","unstructured":"Crippin JS, Jorgensen RA, Dickson ER, et al.: Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am J Gastroenterol 1994, 89(1):47\u201350.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"166_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s005350050250","volume":"34","author":"S Shiomi","year":"1999","unstructured":"Shiomi S, Masaki K, Habu D, et al.: Calcitriol for bone loss in patients with primary biliary cirrhosis. J Gastroenterol 1999, 34(2):241\u2013245.","journal-title":"J Gastroenterol"},{"issue":"10","key":"166_CR31","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","volume":"98","author":"N Guanabens","year":"2003","unstructured":"Guanabens N, Pares A, Ros I, et al.: Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. Am J Gastroenterol 2003, 98(10):2268\u20132274.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"166_CR32","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.20866","volume":"42","author":"CO Zein","year":"2005","unstructured":"\u2022\u2022 Zein CO, Jorgensen RA, Clarke B, et al.: Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial. Hepatology 2005, 42(4):762\u2013771. This is the only randomized, placebo-controlled trial of a bisphosphonate in patients with primary biliary cirrhosis.","journal-title":"Hepatology"},{"issue":"3","key":"166_CR33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00774-009-0042-1","volume":"27","author":"N Guanabens","year":"2009","unstructured":"Guanabens N, Enjuanes A, Alvarez L, et al.: High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue. J Bone Miner Metab 2009, 27(3):347\u2013354.","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"166_CR34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1432-2277.2008.00763.x","volume":"22","author":"A Monegal","year":"2009","unstructured":"Monegal A, Guanabens N, Suarez MJ, et al.: Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial. Transpl Int 2009, 22(2):198\u2013206.","journal-title":"Transpl Int"},{"issue":"4","key":"166_CR35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-144-4-200602210-00005","volume":"144","author":"BA Crawford","year":"2006","unstructured":"Crawford BA, Kam C, Pavlovic J, et al.: Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2006, 144(4):239\u2013248.","journal-title":"Ann Intern Med"},{"issue":"3","key":"166_CR36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1478-3231.1999.tb00034.x","volume":"19","author":"R Olsson","year":"1999","unstructured":"Olsson R, Mattsson LA, Obrant K, et al.: Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis. Liver 1999, 19(3):188\u2013192.","journal-title":"Liver"},{"issue":"1","key":"166_CR37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.288.1.58","volume":"288","author":"S Hulley","year":"2002","unstructured":"Hulley S, Furberg C, Barrett-Connor E, et al.: Noncardiovascular disease outcomes during 6.8\u00a0years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow-up (HERS II). Jama 2002, 288(1):58\u201366.","journal-title":"Jama"},{"issue":"1","key":"166_CR38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1478-3231.2005.01026.x","volume":"25","author":"C Levy","year":"2005","unstructured":"Levy C, Harnois DM, Angulo P, et al.: Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study. Liver Int 2005, 25(1):117\u2013121.","journal-title":"Liver Int"},{"issue":"4","key":"166_CR39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004836-199706000-00012","volume":"24","author":"A Floreani","year":"1997","unstructured":"Floreani A, Zappala F, Fries W, et al.: A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis. J Clin Gastroenterol 1997, 24(4):239\u2013244.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"166_CR40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0270-9139(94)90098-1","volume":"20","author":"M Camisasca","year":"1994","unstructured":"Camisasca M, Crosignani A, Battezzati PM, et al.: Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis. Hepatology 1994, 20(3):633\u2013637.","journal-title":"Hepatology"},{"issue":"4","key":"166_CR41","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0026-0495(87)90201-0","volume":"36","author":"S Feitelberg","year":"1987","unstructured":"Feitelberg S, Epstein S, Ismail F, et al.: Deranged bone mineral metabolism in chronic alcoholism. Metabolism 1987, 36(4):322\u2013326.","journal-title":"Metabolism"},{"issue":"7","key":"166_CR42","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0026-0495(93)90063-T","volume":"42","author":"K Laitinen","year":"1993","unstructured":"Laitinen K, Karkkainen M, Lalla M, et al.: Is alcohol an osteoporosis-inducing agent for young and middle-aged women? Metabolism 1993, 42(7):875\u2013881.","journal-title":"Metabolism"},{"issue":"2","key":"166_CR43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0016-5085(88)90438-6","volume":"94","author":"HC Mitchison","year":"1988","unstructured":"Mitchison HC, Malcolm AJ, Bassendine MF, et al.: Metabolic bone disease in primary biliary cirrhosis at presentation. Gastroenterology 1988, 94(2):463\u2013470.","journal-title":"Gastroenterology"},{"issue":"4","key":"166_CR44","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/0016-5085(90)90635-E","volume":"99","author":"FN Berkum Van","year":"1990","unstructured":"Van Berkum FN, Beukers R, Birkenhager JC, et al.: Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids. Gastroenterology 1990, 99(4):1134\u20131139.","journal-title":"Gastroenterology"},{"issue":"10","key":"166_CR45","first-page":"1356","volume":"85","author":"N Guanabens","year":"1990","unstructured":"Guanabens N, Pares A, Marinoso L, et al.: Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 1990, 85(10):1356\u20131362.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"166_CR46","first-page":"389","volume":"21","author":"KD Lindor","year":"1995","unstructured":"Lindor KD, Janes CH, Crippin JS, et al.: Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 1995, 21(2):389\u2013392.","journal-title":"Hepatology"},{"issue":"9","key":"166_CR47","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/lt.20874","volume":"12","author":"MM Guichelaar","year":"2006","unstructured":"\u2022 Guichelaar MM, Kendall R, Malinchoc M, et al.: Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl 2006, 12(9):1390\u20131402. A thorough review of hepatic osteodystrophy in patients with end stage liver disease before and after liver transplantation. Recommendations are given for screening patients for osteoporosis and for treatment.","journal-title":"Liver Transpl"},{"issue":"5","key":"166_CR48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1440-1746.1996.tb00284.x","volume":"11","author":"CC Chen","year":"1996","unstructured":"Chen CC, Wang SS, Jeng FS, et al.: Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol 1996, 11(5):417\u2013421.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"166_CR49","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.510280315","volume":"28","author":"FJ Gallego-Rojo","year":"1998","unstructured":"Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, et al.: Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998, 28(3):695\u2013699.","journal-title":"Hepatology"},{"issue":"2","key":"166_CR50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.1840120214","volume":"12","author":"HL Bonkovsky","year":"1990","unstructured":"Bonkovsky HL, Hawkins M, Steinberg K, et al.: Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 1990, 12(2):273\u2013280.","journal-title":"Hepatology"},{"issue":"2","key":"166_CR51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s002239900205","volume":"60","author":"A Monegal","year":"1997","unstructured":"Monegal A, Navasa M, Guanabens N, et al.: Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997, 60(2):148\u2013154.","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"166_CR52","first-page":"1809","volume":"24","author":"L Sinigaglia","year":"1997","unstructured":"Sinigaglia L, Fargion S, Fracanzani AL, et al.: Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol 1997, 24(9):1809\u20131813.","journal-title":"J Rheumatol"},{"key":"166_CR53","doi-asserted-by":"crossref","first-page":"472A","DOI":"10.1016\/S0168-8278(99)80107-X","volume":"30","author":"A Pares","year":"1999","unstructured":"Pares A, Guanabens N, and Ros I: Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. Hepatology 1999, 30:472A.","journal-title":"Hepatology"},{"issue":"3","key":"166_CR54","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ajcn\/36.3.426","volume":"36","author":"O Epstein","year":"1982","unstructured":"Epstein O, Kato Y, Dick R, et al.: Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis. Am J Clin Nutr 1982, 36(3):426\u2013430.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"166_CR55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0016-5085(97)70098-2","volume":"113","author":"N Guanabens","year":"1997","unstructured":"Guanabens N, Pares A, Monegal A, et al.: Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2\u00a0years. Gastroenterology 1997, 113(1):219\u2013224.","journal-title":"Gastroenterology"},{"issue":"2","key":"166_CR56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-8278(97)80048-7","volume":"26","author":"FH Wolfhagen","year":"1997","unstructured":"Wolfhagen FH, van Buuren HR, den Ouden JW, et al.: Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study. J Hepatol 1997, 26(2):325\u2013330.","journal-title":"J Hepatol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-010-0166-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-010-0166-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-010-0166-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T08:42:47Z","timestamp":1559810567000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-010-0166-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,23]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["166"],"URL":"https:\/\/doi.org\/10.1007\/s11894-010-0166-4","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,23]]}}}